CD8A and neoplasm: In support of this, IgG2a administration in the mice used here led to the formation of anti-rat antibodies in mice with B16-F10 but not EO771 tumors [34], but nevertheless significantly reduced the proportion of CD8+ T cells within the tumor in both tumor types (manuscript under review).